Byles et al. confirmed that SIRT1 functions as a corepressor with ZEB1 specifically to suppress E-cadherin transcription and upregulate mesenchymal markers during the EMT in prostate cancer [25]. This evidence concerns the gene SIRT1 and prostate cancer.